source
- Dr Cohen on Frontline Chemotherapy Selection in Metastatic Pancreatic CancerDeirdre J. Cohen, MD, MS, discusses clinical decision-making and the comparative efficacy of FOLFIRINOX and NALIRIFOX in metastatic pancreatic cancer.onclive · 2mo ago↗ source
- Dr Pant on Managing Toxicities With Daraxonrasib in PDACShubham Pant, MD, MBBS, discusses the management of dermatologic and GI toxicities associated with the RAS(ON) inhibitor daraxonrasib.onclive · 2mo ago↗ source
- HS-10504 Shows Promising Activity in EGFR C797S–Mutant NSCLC After TKI ResistancePhase 1 data show HS-10504 yields encouraging responses and manageable safety in EGFR C797S–mutant NSCLC post TKI therapy.onclive · 2mo ago↗ source